Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity ...
Q2 2026
Aug 5, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 3, 2026
Q4 2025
Q3 2025
Nov 5, 2025